W8MD Diet | COVID-19 portal | Vitamin D | Vaccine | Keto

WikiMD is the world's largest medical encyclopedia with
13,591 pages, 4,139,072 edits & 37,811,477 views.

Free unbiased diet, health and wellness info!


From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search
Syringe with Certolizumab
Syringe with Certolizumab

Information about Certolizumab

Certolizumab is a Fab fragment of a monoclonal antibody to human tumor necrosis factor alpha (TNFα) which has potent antiinflammatory activity and is used in the therapy of severe rheumatoid arthritis and inflammatory bowel disease.

Other names

Certolizumab pegol

Mechanism of action of Certolizumab

Recombinant monoclonal antibody to TNFα linked to polyethylene glycol. The monoclonal antibody fragment binds avidly to serum and tissue bound TNFα causing its inactivation and degradation. Inhibition of TNFα activity leads to modulation of the inflammatory and pain pathways activated by this cytokine. The polyethylene glycol alters its pharmacokinetics, prolonging its half-life, and allowing for every 4 week administration.

FDA approval information for Certolizumab

Certolizumab was approved in the United States in 2007 for use in Crohn disease and its indications were subsequently extended to rheumatoid arthritis and psoriatic arthritis and ankylosing spondylitis.

Clinical use of Certolizumab

Certolizumab is considered a disease modifying antirheumatic drug (DMARD) and has been shown to improve symptoms as well as joint and cartilage damage in the inflammatory arthritides.

Dosage and administration for Certolizumab

Certolizumab is available as lyophilized powder for reconstitution or in prefilled syringes as 200 mg/1.0 mL under the brand name of Cimzia. The typical dose of certolizumab for Crohn disease is 200 to 400 mg subcutaneously initially and at weeks 2 and 4, followed by 400 mg every 4 weeks. Recommendations vary slightly by indication.

Side effects of Certolizumab

  • Common side effects include injection site reactions, headache, nausea, abdominal discomfort, diarrhea, skin rash and fever.
  • Severe side effects include bone marrow suppression and hypersensitivity reactions.
  • TNFα antagonists are also capable of causing immune suppression, which can result in reactivation of microbial infections including tuberculosis and hepatitis B.

Brand name for Certolizumab

Certolizumab – Cimzia®

Drug class for Certolizumab

Antirheumatic Agents; Gastrointestinal Agents

Cost and Coupons - Certolizumab

Reviews for Certolizumab

Learn more about Certolizumab

Latest research - Certolizumab

Clinical trials

External links

Medicine icon
Medicine icon

This WikiMD article Certolizumab is a stub. If you are familiar with the topic Certolizumab, you can help us. Paid editors welcome!


Certolizumab is part of WikiMD's free ^articles!

^Certolizumab (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available